
|Videos|October 11, 2016
Specialty Pharmacy, Payer Goals in Atopic Dermatitis Management
Advertisement
Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Cheryl Allen, BS Pharm, MBA; Jeffrey D. Dunn, Pharm D, MBA; and Jonathan Silverberg, MD, PhD, MPH, provide insight on specialty pharmacy and payer goals in the management of atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
5














































































































































































































